| 1 |
Avraham Moshe Rosenwasser |
Unknown |
5 |
| 1 |
Signe Unverricht |
Basf Se |
5 |
| 1 |
David Rosenwasser |
Unknown |
5 |
| #4 |
Hubert Josien |
Merck |
3 |
| #5 |
Mark S. Cole |
Abbott |
2 |
| #5 |
Iyassu Sebhat |
Merck |
2 |
| #5 |
Samad Syed |
Finetex |
2 |
| #5 |
Mark Smith |
Illumina Cambridge Limited |
2 |
| #5 |
John Mc Kittrick |
Isp Investments |
2 |
| #5 |
David Lee |
AT&T |
2 |
| #11 |
Francis Gomes |
Bel-Art Products |
1 |
| #11 |
Khalid Yousseff |
Intel |
1 |
| #11 |
Drupesh Patel |
Isp Investments |
1 |
| #11 |
Bryan Evans |
Gateway Consultants Group |
1 |
| #11 |
Zbigniew Kopytnik |
Knoa Software |
1 |
| #11 |
Umesh Marthi |
Citibank, N.A. |
1 |
| #11 |
Alejandro Ortega |
Schering-Plough Healthcare Products |
1 |
| #11 |
Cheng Chi |
IBM |
1 |
| #11 |
Craig Gotsman |
AT&T |
1 |
| #11 |
Michael B. Field |
The University Of Chicago |
1 |
| #11 |
Daniel Winigrad |
Ekco Housewares |
1 |
| #11 |
Elena N. Chabala |
Vyteris |
1 |
| #11 |
Shapour Neshatfar |
AT&T |
1 |
| #11 |
Leslie Jo Morgan |
Lever Brothers Company, Division Of Conopco |
1 |
| #11 |
Evelyn Lomax |
— |
1 |
| #11 |
Gabriel Valdez |
AT&T |
1 |
| #11 |
Karel Brands |
Merck |
1 |
| #11 |
Qing He |
Biosante Pharmaceuticals |
1 |
| #11 |
Timothy O'Toole |
Johnson & Johnson |
1 |
| #11 |
Ginger Xu-qiang Yang |
Merck |
1 |
| #11 |
John J. Merianos |
Isp Investments |
1 |
| #11 |
Jose Reyes-Gavilan |
Afton Chemical |
1 |
| #11 |
Christos Kondilis |
Trading Technologies International |
1 |
| #11 |
Michael P. McMahon |
Prysm |
1 |